Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mott

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry|May 16, 2013
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity studyBryan T Mott, Ran He, Xiaochun Chen, et al.
Journal of Biomolecular Screening|November 30, 2012
High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphataseEric S McCoy, Wendy A Lea, Bryan T Mott, et al.
Glia|April 20, 2004
Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine productionRyan T Mott, Ghania Ait-Ghezala, Terrence Town, et al.
Oncology Letters|January 8, 2014
Relapsing intracranial plasma cell granuloma: A case reportJaclyn J Renfrow, Jerry W Mitchell, Michael Goodman, et al.
Frontiers in Oncology|February 7, 2022
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable PharmacologyAmanda B Kagan, Blake S Moses, Bryan T Mott, et al.
Journal of Medicinal Chemistry|April 9, 2010
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondiiChristopher P Hencken, Lorraine Jones-Brando, Claudia Bordón, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2014
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemetherRyan C Conyers, Jennifer R Mazzone, Maxime A Siegler, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2016
Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory siteMonica Kasbekar, Gerhard Fischer, Bryan T Mott, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2023
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivativeAmanda B Kagan, Blake S Moses, Rena Lapidus, et al.
Journal of Medicinal Chemistry|October 16, 2004
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitorsApurba K Bhattacharjee, Jeanne A Geyer, Cassandra L Woodard, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry|May 16, 2013
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity studyBryan T Mott, Ran He, Xiaochun Chen, et al.
Journal of Biomolecular Screening|November 30, 2012
High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphataseEric S McCoy, Wendy A Lea, Bryan T Mott, et al.
Glia|April 20, 2004
Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine productionRyan T Mott, Ghania Ait-Ghezala, Terrence Town, et al.
Oncology Letters|January 8, 2014
Relapsing intracranial plasma cell granuloma: A case reportJaclyn J Renfrow, Jerry W Mitchell, Michael Goodman, et al.
Frontiers in Oncology|February 7, 2022
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable PharmacologyAmanda B Kagan, Blake S Moses, Bryan T Mott, et al.
Journal of Medicinal Chemistry|April 9, 2010
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondiiChristopher P Hencken, Lorraine Jones-Brando, Claudia Bordón, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2014
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemetherRyan C Conyers, Jennifer R Mazzone, Maxime A Siegler, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2016
Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory siteMonica Kasbekar, Gerhard Fischer, Bryan T Mott, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2023
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivativeAmanda B Kagan, Blake S Moses, Rena Lapidus, et al.
Journal of Medicinal Chemistry|October 16, 2004
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitorsApurba K Bhattacharjee, Jeanne A Geyer, Cassandra L Woodard, et al.
Pageof 12